# DUSP14

## Overview
DUSP14 is a gene that encodes the protein dual specificity phosphatase 14, which is a member of the dual specificity phosphatase family. This family of proteins is characterized by their ability to dephosphorylate both tyrosine and serine/threonine residues, thereby playing a critical role in the regulation of mitogen-activated protein kinase (MAPK) signaling pathways. The DUSP14 protein, also known as MKP6, is involved in modulating cellular processes such as proliferation, differentiation, and stress responses by deactivating key signaling molecules. It is particularly significant in immune regulation, where it influences T cell receptor (TCR) signaling and helps maintain immune homeostasis. DUSP14's activity is crucial for preventing excessive immune activation and autoimmune conditions. The protein is active in both the cytoplasm and nucleus, where it interacts with various signaling components, including TAK1 and TAB1, to exert its regulatory functions (Yang2014DualSpecificity; Park2009PTP).

## Structure
The molecular structure of human dual-specificity phosphatase 14 (DUSP14) has been elucidated using molecular replacement techniques, achieving a resolution of 1.88 Å. The protein consists of a central five-stranded beta-sheet flanked by helices on both sides. At the C-terminal end, DUSP14 forms a two-stranded antiparallel beta-sheet with an extending alpha-helix (Lountos2009Overproduction). The catalytic domain of DUSP14 includes a well-resolved active site near the catalytic Cys111, which is modeled as a phosphate ion. The active site is characterized by the motif HCXXGXXRS(T), where X represents variable residues. This motif is crucial for the enzyme's catalytic function, involving a conserved cysteine thiolate anion that attacks the tyrosine phosphate to form a cysteinylphosphate intermediate (Lountos2009Overproduction).

DUSP14 primarily exists as a monomer, with minimal dimer interface interactions, suggesting that the monomer is the biologically relevant unit (Lountos2009Overproduction). The protein's structure was validated with a MolProbity score of 1.33, indicating high quality, and the Ramachandran plot showed that 90% of residues are in the most favored regions (Lountos2009Overproduction). The electrostatic surface potential around the binding pocket is predominantly hydrophobic on one side and positively charged on the other, which influences substrate specificity (Lountos2009Overproduction).

## Function
DUSP14, also known as MKP6, is a dual-specificity phosphatase that plays a significant role in regulating mitogen-activated protein kinase (MAPK) signaling pathways by dephosphorylating both tyrosine and serine/threonine residues. This regulation is crucial for maintaining cellular homeostasis and modulating various cellular processes, including proliferation, differentiation, and stress responses (Park2009PTP). In T cells, DUSP14 negatively regulates T cell receptor (TCR) signaling by dephosphorylating and inactivating TAB1, a component involved in the activation of TAK1, which is part of the signaling pathway. This action helps control immune responses and prevent excessive immune activation (Yang2014DualSpecificity).

DUSP14 is active in both the cytoplasm and nucleus, where it influences immune responses and cellular signaling. It interacts with TGF-b-activated kinase 1 (TAK1)-binding protein 1 (TAB1) and dephosphorylates it, leading to the inactivation of the TAB1-TAK1 complex in T cells. This interaction is crucial for modulating the phosphorylation levels of downstream molecules such as JNK and IkB kinase, thereby influencing T cell activation and cytokine production (Yang2014DualSpecificity). DUSP14's activity is essential for maintaining immune homeostasis and preventing autoimmune conditions by modulating TCR signaling pathways (Yang2014DualSpecificity).

## Clinical Significance
DUSP14 has been implicated in various diseases due to its role in immune regulation and signaling pathways. Alterations in DUSP14 expression or function can impact immune responses, potentially leading to autoimmune diseases. DUSP14-deficient mice exhibit enhanced T-cell-mediated immune responses and are more susceptible to experimental autoimmune encephalomyelitis, a model for multiple sclerosis, indicating its role in controlling autoimmune responses (Yang2014DualSpecificity; Chuang2019MAP4K).

In the context of infectious diseases, DUSP14 has been linked to genetic susceptibility to tuberculosis. A low-expression genotype of DUSP14 is associated with high transcript levels of IFNGR2 and STAT1, which may offer protection against early tuberculosis development (Lang2019DualSpecificity).

DUSP14 also plays a role in cancer. It is up-regulated in certain cancers, such as lymphoid neoplasm diffuse large B-cell lymphoma and thymoma, although the precise roles and clinical significance of these alterations remain unclear (Gao2021The). The regulation of NF-κB activation by DUSP14 suggests its potential involvement in inflammatory diseases, as its dysregulation could lead to enhanced inflammatory responses (Zheng2013The).

## Interactions
DUSP14, also known as dual specificity phosphatase 14, interacts with several proteins involved in key signaling pathways. It specifically interacts with TAK1 (TGF-β-activated kinase 1), a crucial component in the TNF- and IL-1-induced NF-κB activation pathways. This interaction is independent of DUSP14's enzymatic activity and is enhanced by TNF or IL-1 stimulation. DUSP14 dephosphorylates TAK1 at Thr-187, which is necessary for its inhibitory effect on TAK1-mediated NF-κB activation (Zheng2013The).

DUSP14 also interacts with TAB1 (TAK1-binding protein 1) in the T cell receptor (TCR) signaling pathway. It directly dephosphorylates TAB1 at Ser 438, which is crucial for regulating the TAB1-TAK1 complex and its downstream signaling molecules. This interaction negatively regulates TCR signaling by attenuating TAB1 activation (Yang2014DualSpecificity).

Additionally, DUSP14 is methylated by PRMT5 at specific arginine residues, which enhances its interaction with TRAF2, an E3 ligase. This methylation promotes TRAF2-mediated Lys63-linked ubiquitination of DUSP14, which is essential for its phosphatase activity during TCR signaling (Yang2018Induction).


## References


[1. (Zheng2013The) Hao Zheng, Qi Li, Rui Chen, Jing Zhang, Yong Ran, Xiao He, Shu Li, and Hong-Bing Shu. The dual-specificity phosphatase dusp14 negatively regulates tumor necrosis factor- and interleukin-1-induced nuclear factor-κb activation by dephosphorylating the protein kinase tak1. Journal of Biological Chemistry, 288(2):819–825, January 2013. URL: http://dx.doi.org/10.1074/jbc.m112.412643, doi:10.1074/jbc.m112.412643. This article has 43 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m112.412643)

[2. (Park2009PTP) Jae Eun Park, Byoung Chul Park, Mina Song, Sung Goo Park, Do Hee Lee, So-Young Park, Jae Hoon Kim, and Sayeon Cho. Ptp inhibitor iv protects jnk kinase activity by inhibiting dual-specificity phosphatase 14 (dusp14). Biochemical and Biophysical Research Communications, 387(4):795–799, October 2009. URL: http://dx.doi.org/10.1016/j.bbrc.2009.07.127, doi:10.1016/j.bbrc.2009.07.127. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2009.07.127)

[3. (Yang2018Induction) Chia‐Yu Yang, Li‐Li Chiu, Chih‐Chi Chang, Huai‐Chia Chuang, and Tse‐Hua Tan. Induction of dusp14 ubiquitination by prmt5‐mediated arginine methylation. The FASEB Journal, 32(12):6760–6770, June 2018. URL: http://dx.doi.org/10.1096/fj.201800244RR, doi:10.1096/fj.201800244rr. This article has 20 citations.](https://doi.org/10.1096/fj.201800244RR)

[4. (Chuang2019MAP4K) Huai-Chia Chuang and Tse-Hua Tan. Map4k family kinases and dusp family phosphatases in t-cell signaling and systemic lupus erythematosus. Cells, 8(11):1433, November 2019. URL: http://dx.doi.org/10.3390/cells8111433, doi:10.3390/cells8111433. This article has 63 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cells8111433)

[5. (Lountos2009Overproduction) George T. Lountos, Joseph E. Tropea, Scott Cherry, and David S. Waugh. Overproduction, purification and structure determination of human dual-specificity phosphatase 14. Acta Crystallographica Section D Biological Crystallography, 65(10):1013–1020, September 2009. URL: http://dx.doi.org/10.1107/S0907444909023762, doi:10.1107/s0907444909023762. This article has 24 citations.](https://doi.org/10.1107/S0907444909023762)

[6. (Yang2014DualSpecificity) Chia-Yu Yang, Ju-Pi Li, Li-Li Chiu, Joung-Liang Lan, Der-Yuan Chen, Huai-Chia Chuang, Ching-Yu Huang, and Tse-Hua Tan. Dual-specificity phosphatase 14 (dusp14/mkp6) negatively regulates tcr signaling by inhibiting tab1 activation. The Journal of Immunology, 192(4):1547–1557, February 2014. URL: http://dx.doi.org/10.4049/jimmunol.1300989, doi:10.4049/jimmunol.1300989. This article has 54 citations.](https://doi.org/10.4049/jimmunol.1300989)

[7. (Gao2021The) Ping-Ping Gao, Xiao-Wei Qi, Na Sun, Yuan-Yuan Sun, Ye Zhang, Xuan-Ni Tan, Jun Ding, Fei Han, and Yi Zhang. The emerging roles of dual-specificity phosphatases and their specific characteristics in human cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1876(1):188562, August 2021. URL: http://dx.doi.org/10.1016/j.bbcan.2021.188562, doi:10.1016/j.bbcan.2021.188562. This article has 19 citations.](https://doi.org/10.1016/j.bbcan.2021.188562)

[8. (Lang2019DualSpecificity) Roland Lang and Faizal Raffi. Dual-specificity phosphatases in immunity and infection: an update. International Journal of Molecular Sciences, 20(11):2710, June 2019. URL: http://dx.doi.org/10.3390/ijms20112710, doi:10.3390/ijms20112710. This article has 95 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms20112710)